Clinical Trial Detail

NCT ID NCT03575013
Title A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rohan Garje
Indications

urethra transitional cell carcinoma

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

Therapies

Avelumab + Docetaxel

Age Groups: senior adult

No variant requirements are available.